CVS Health Corp (NYSE:CVS) Shares Sold by Vestmark Advisory Solutions Inc.

Vestmark Advisory Solutions Inc. lessened its stake in CVS Health Corp (NYSE:CVS) by 11.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 12,380 shares of the pharmacy operator’s stock after selling 1,649 shares during the quarter. Vestmark Advisory Solutions Inc.’s holdings in CVS Health were worth $781,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Baldwin Brothers Inc. MA grew its position in CVS Health by 1.1% in the 3rd quarter. Baldwin Brothers Inc. MA now owns 14,911 shares of the pharmacy operator’s stock worth $941,000 after purchasing an additional 165 shares during the last quarter. Mutual Advisors LLC grew its position in CVS Health by 0.8% in the 2nd quarter. Mutual Advisors LLC now owns 20,641 shares of the pharmacy operator’s stock worth $1,125,000 after purchasing an additional 172 shares during the last quarter. Enterprise Financial Services Corp grew its position in CVS Health by 3.7% in the 3rd quarter. Enterprise Financial Services Corp now owns 5,156 shares of the pharmacy operator’s stock worth $325,000 after purchasing an additional 185 shares during the last quarter. Fiduciary Group LLC grew its position in CVS Health by 3.2% in the 2nd quarter. Fiduciary Group LLC now owns 6,485 shares of the pharmacy operator’s stock worth $353,000 after purchasing an additional 200 shares during the last quarter. Finally, Legacy Advisors LLC grew its position in CVS Health by 2.5% in the 3rd quarter. Legacy Advisors LLC now owns 8,048 shares of the pharmacy operator’s stock worth $508,000 after purchasing an additional 200 shares during the last quarter. Institutional investors and hedge funds own 75.92% of the company’s stock.

In related news, EVP Joshua Matthew Flum sold 17,703 shares of the stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $63.00, for a total transaction of $1,115,289.00. Following the completion of the sale, the executive vice president now directly owns 36,163 shares of the company’s stock, valued at $2,278,269. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Troyen A. Brennan sold 23,604 shares of the stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $68.00, for a total transaction of $1,605,072.00. Following the sale, the executive vice president now directly owns 107,921 shares of the company’s stock, valued at $7,338,628. The disclosure for this sale can be found here. Over the last three months, insiders have sold 49,437 shares of company stock valued at $3,248,811. Company insiders own 0.53% of the company’s stock.

Several research analysts have commented on CVS shares. Deutsche Bank started coverage on shares of CVS Health in a research report on Thursday, September 12th. They issued a “buy” rating and a $91.00 target price for the company. ValuEngine upgraded shares of CVS Health from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 2nd. Cowen set a $76.00 target price on shares of CVS Health and gave the stock a “buy” rating in a research report on Monday, October 21st. Wells Fargo & Co upped their target price on shares of CVS Health from $62.00 to $72.00 and gave the stock a “market perform” rating in a research report on Friday, November 8th. Finally, Bank of America upped their target price on shares of CVS Health from $72.00 to $75.00 and gave the stock a “buy” rating in a research report on Thursday, September 12th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $77.59.

Shares of NYSE:CVS traded up $0.47 during trading on Wednesday, reaching $72.82. The company had a trading volume of 5,173,832 shares, compared to its average volume of 10,074,047. The firm’s fifty day moving average is $65.34 and its 200 day moving average is $58.93. The firm has a market capitalization of $94.28 billion, a PE ratio of 10.29, a price-to-earnings-growth ratio of 1.57 and a beta of 0.86. CVS Health Corp has a twelve month low of $51.72 and a twelve month high of $82.15. The company has a debt-to-equity ratio of 1.32, a quick ratio of 0.61 and a current ratio of 0.92.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.84 earnings per share for the quarter, topping analysts’ consensus estimates of $1.77 by $0.07. The company had revenue of $64.81 billion during the quarter, compared to analyst estimates of $62.99 billion. CVS Health had a net margin of 1.83% and a return on equity of 15.45%. The business’s revenue for the quarter was up 36.5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.73 EPS. Equities analysts predict that CVS Health Corp will post 7.01 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Monday, November 4th. Investors of record on Thursday, October 24th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.75%. The ex-dividend date of this dividend was Wednesday, October 23rd. CVS Health’s dividend payout ratio is presently 28.25%.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

See Also: How Buying a Call Option Works

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.